BiomedicalPublications

Current Opinion in Hematology

Lippincott Williams & Wilkins·United States·ISSN 1065-6251

Subscription or hybridMedicine

Current Opinion in Hematology is published by Lippincott Williams & Wilkins as a subscription journal (ISSN 1065-6251). No open-access article processing charge is listed; publishing is typically via subscription. Its OpenAlex h-index is 126. Figures on this page are sourced from OpenAlex and DOAJ and should be confirmed on the journal’s own site before submission.

Cost to publish

Subscription

No open-access fee found. Publishing is typically free to the author.

Checked · How we source APCs

Time to publication

—

Not reported to DOAJ.

h-index

126

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

3.4

Average citations to articles from the previous two years.

What it costs to publish here

We could not find a published fee for Current Opinion in Hematology. As a subscription or hybrid journal, publishing is normally free unless you choose the open-access option.

Peer review and licensing

Review modelNot reported
LicenceNot reported
Author keeps copyrightNot reported
Plagiarism screeningNot reported
Editorial boardNot linked in DOAJ
LanguagesNot reported

Verification checks

2 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsNot listed. Many legitimate subscription journals are not in DOAJ, so this alone means little.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredNo declared model found in DOAJ.
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects Current Opinion in Hematology publishes most, derived from the topics assigned to its indexed articles.

Hematopoietic Stem Cell TransplantationAcute Myeloid Leukemia ResearchPlatelet Disorders and TreatmentsErythrocyte Function and PathophysiologyHemoglobinopathies and Related DisordersBlood groups and transfusionChronic Myeloid Leukemia TreatmentsMyeloproliferative Neoplasms: Diagnosis and TreatmentBlood transfusion and managementBlood disorders and treatments

Publication record

Indexed articles2,348
Total citations84,701
i10-index1,586
Most recent indexed article2026
All ISSNs1065-6251, 1080-8213, 1531-7048

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.